 | • レポートコード：QYR9N7988 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、ルフィナミドのグローバル市場について調査・分析したレポートで、種類別（タブレット、経口懸濁液）、用途別（大人、小児患者）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・ルフィナミドの世界市場規模 ・主要企業別市場シェア ・ルフィナミドの世界市場規模：種類別（タブレット、経口懸濁液） ・ルフィナミドの世界市場規模：用途別（大人、小児患者） ・ルフィナミドのアメリカ市場規模（種類別、用途別） ・ルフィナミドのヨーロッパ市場規模（種類別、用途別） ・ルフィナミドの中国市場規模（種類別、用途別） ・ルフィナミドの日本市場規模（種類別、用途別） ・ルフィナミドの東南アジア市場規模（種類別、用途別） ・ルフィナミドのインド市場規模（種類別、用途別） ・ルフィナミドの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・ルフィナミドの世界市場予測（2019年-2025年） ・ルフィナミドの地域別市場予測（2019年-2025年） ... |
Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders.In 2018, the global Rufinamide market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Rufinamide status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rufinamide development in United States, Europe and China.
The key players covered in this study
Eisai
Glenmark Pharms
Mylan
West-ward Pharms
…
Market segment by Type, the product can be split into
Tablets
Oral suspension
Market segment by Application, split into
Adults
Pediatric patients
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Rufinamide status, future forecast, growth opportunity, key market and key players.
To present the Rufinamide development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Rufinamide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Rufinamide Market Size Growth Rate by Type (2014-2025)
1.4.2 Tablets
1.4.3 Oral suspension
1.5 Market by Application
1.5.1 Global Rufinamide Market Share by Application (2014-2025)
1.5.2 Adults
1.5.3 Pediatric patients
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Rufinamide Market Size
2.2 Rufinamide Growth Trends by Regions
2.2.1 Rufinamide Market Size by Regions (2014-2025)
2.2.2 Rufinamide Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Rufinamide Market Size by Manufacturers
3.1.1 Global Rufinamide Revenue by Manufacturers (2014-2019)
3.1.2 Global Rufinamide Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Rufinamide Market Concentration Ratio (CR5 and HHI)
3.2 Rufinamide Key Players Head office and Area Served
3.3 Key Players Rufinamide Product/Solution/Service
3.4 Date of Enter into Rufinamide Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Rufinamide Market Size by Type (2014-2019)
4.2 Global Rufinamide Market Size by Application (2014-2019)
5 United States
5.1 United States Rufinamide Market Size (2014-2019)
5.2 Rufinamide Key Players in United States
5.3 United States Rufinamide Market Size by Type
5.4 United States Rufinamide Market Size by Application
6 Europe
6.1 Europe Rufinamide Market Size (2014-2019)
6.2 Rufinamide Key Players in Europe
6.3 Europe Rufinamide Market Size by Type
6.4 Europe Rufinamide Market Size by Application
7 China
7.1 China Rufinamide Market Size (2014-2019)
7.2 Rufinamide Key Players in China
7.3 China Rufinamide Market Size by Type
7.4 China Rufinamide Market Size by Application
8 Japan
8.1 Japan Rufinamide Market Size (2014-2019)
8.2 Rufinamide Key Players in Japan
8.3 Japan Rufinamide Market Size by Type
8.4 Japan Rufinamide Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Rufinamide Market Size (2014-2019)
9.2 Rufinamide Key Players in Southeast Asia
9.3 Southeast Asia Rufinamide Market Size by Type
9.4 Southeast Asia Rufinamide Market Size by Application
10 India
10.1 India Rufinamide Market Size (2014-2019)
10.2 Rufinamide Key Players in India
10.3 India Rufinamide Market Size by Type
10.4 India Rufinamide Market Size by Application
11 Central & South America
11.1 Central & South America Rufinamide Market Size (2014-2019)
11.2 Rufinamide Key Players in Central & South America
11.3 Central & South America Rufinamide Market Size by Type
11.4 Central & South America Rufinamide Market Size by Application
12 International Players Profiles
12.1 Eisai
12.1.1 Eisai Company Details
12.1.2 Company Description and Business Overview
12.1.3 Rufinamide Introduction
12.1.4 Eisai Revenue in Rufinamide Business (2014-2019)
12.1.5 Eisai Recent Development
12.2 Glenmark Pharms
12.2.1 Glenmark Pharms Company Details
12.2.2 Company Description and Business Overview
12.2.3 Rufinamide Introduction
12.2.4 Glenmark Pharms Revenue in Rufinamide Business (2014-2019)
12.2.5 Glenmark Pharms Recent Development
12.3 Mylan
12.3.1 Mylan Company Details
12.3.2 Company Description and Business Overview
12.3.3 Rufinamide Introduction
12.3.4 Mylan Revenue in Rufinamide Business (2014-2019)
12.3.5 Mylan Recent Development
12.4 West-ward Pharms
12.4.1 West-ward Pharms Company Details
12.4.2 Company Description and Business Overview
12.4.3 Rufinamide Introduction
12.4.4 West-ward Pharms Revenue in Rufinamide Business (2014-2019)
12.4.5 West-ward Pharms Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Rufinamide Key Market Segments
Table Key Players Rufinamide Covered
Table Global Rufinamide Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Rufinamide Market Size Market Share by Type 2014-2025
Figure Tablets Figures
Table Key Players of Tablets
Figure Oral suspension Figures
Table Key Players of Oral suspension
Table Global Rufinamide Market Size Growth by Application 2014-2025 (Million US$)
Figure Adults Case Studies
Figure Pediatric patients Case Studies
Figure Rufinamide Report Years Considered
Table Global Rufinamide Market Size 2014-2025 (Million US$)
Figure Global Rufinamide Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Rufinamide Market Size by Regions 2014-2025 (Million US$)
Table Global Rufinamide Market Size by Regions 2014-2019 (Million US$)
Table Global Rufinamide Market Share by Regions 2014-2019
Figure Global Rufinamide Market Share by Regions 2014-2019
Figure Global Rufinamide Market Share by Regions 2019
Table Market Top Trends
Table Global Rufinamide Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Rufinamide Market Share by Manufacturers (2014-2019)
Figure Global Rufinamide Market Share by Manufacturers in 2018
Table Global Rufinamide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Rufinamide Product/Solution/Service
Table Date of Enter into Rufinamide Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Rufinamide Market Size by Type (2014-2019) (Million US$)
Table Global Rufinamide Market Size Share by Type (2014-2019)
Figure Global Rufinamide Market Size Market Share by Type (2014-2019)
Table Global Rufinamide Market Size by Application (2014-2019) (Million US$)
Table Global Rufinamide Market Size Share by Application (2014-2019)
Figure Global Rufinamide Market Size Market Share by Application (2014-2019)
Figure Global Rufinamide Revenue Market Share by Application in 2018
Figure United States Rufinamide Market Size 2014-2019 (Million US$)
Table United States Key Players Rufinamide Revenue (2018-2019) (Million US$)
Table United States Key Players Rufinamide Market Share (2018-2019)
Table United States Rufinamide Market Size by Type (2014-2019) (Million US$)
Table United States Rufinamide Market Share by Type (2014-2019)
Table United States Rufinamide Market Size by Application (2014-2019) (Million US$)
Table United States Rufinamide Market Share by Application (2014-2019)
Figure Europe Rufinamide Market Size 2014-2019 (Million US$)
Table Europe Key Players Rufinamide Revenue (2018-2019) (Million US$)
Table Europe Key Players Rufinamide Market Share (2018-2019)
Table Europe Rufinamide Market Size by Type (2014-2019) (Million US$)
Table Europe Rufinamide Market Share by Type (2014-2019)
Table Europe Rufinamide Market Size by Application (2014-2019) (Million US$)
Table Europe Rufinamide Market Share by Application (2014-2019)
Figure China Rufinamide Market Size 2014-2019 (Million US$)
Table China Key Players Rufinamide Revenue (2018-2019) (Million US$)
Table China Key Players Rufinamide Market Share (2018-2019)
Table China Rufinamide Market Size by Type (2014-20189) (Million US$)
Table China Rufinamide Market Share by Type (2014-2019)
Table China Rufinamide Market Size by Application (2014-2019) (Million US$)
Table China Rufinamide Market Share by Application (2014-2019)
Figure Japan Rufinamide Market Size 2014-2019 (Million US$)
Table Japan Key Players Rufinamide Revenue (2018-2019) (Million US$)
Table Japan Key Players Rufinamide Market Share (2018-2019)
Table Japan Rufinamide Market Size by Type (2014-2019) (Million US$)
Table Japan Rufinamide Market Share by Type (2014-2019)
Table Japan Rufinamide Market Size by Application (2014-2019) (Million US$)
Table Japan Rufinamide Market Share by Application (2014-2019)
Figure Southeast Asia Rufinamide Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Rufinamide Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Rufinamide Market Share (2018-2019)
Table Southeast Asia Rufinamide Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Rufinamide Market Share by Type (2014-2019)
Table Southeast Asia Rufinamide Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Rufinamide Market Share by Application (2014-2019)
Figure India Rufinamide Market Size 2014-2019 (Million US$)
Table India Key Players Rufinamide Revenue (2018-2019) (Million US$)
Table India Key Players Rufinamide Market Share (2018-2019)
Table India Rufinamide Market Size by Type (2014-2019) (Million US$)
Table India Rufinamide Market Share by Type (2014-2019)
Table India Rufinamide Market Size by Application (2014-2019) (Million US$)
Table India Rufinamide Market Share by Application (2014-2019)
Figure Central & South America Rufinamide Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Rufinamide Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Rufinamide Market Share (2018-2019)
Table Central & South America Rufinamide Market Size by Type (2014-2019) (Million US$)
Table Central & South America Rufinamide Market Share by Type (2014-2019)
Table Central & South America Rufinamide Market Size by Application (2014-2019) (Million US$)
Table Central & South America Rufinamide Market Share by Application (2014-2019)
Table Eisai Company Details
Table Eisai Revenue in Rufinamide Business (2014-2019) (Million US$)
Figure Eisai Revenue Growth Rate in Rufinamide Business (2014-2019)
Table Eisai Recent Development
Table Glenmark Pharms Company Details
Table Glenmark Pharms Revenue in Rufinamide Business (2014-2019)(Million US$)
Figure Glenmark Pharms Revenue Growth Rate in Rufinamide Business (2014-2019)
Table Glenmark Pharms Recent Development
Table Mylan Company Details
Table Mylan Revenue in Rufinamide Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Rufinamide Business (2014-2019)
Table Mylan Recent Development
Table West-ward Pharms Company Details
Table West-ward Pharms Revenue in Rufinamide Business (2014-2019)(Million US$)
Figure West-ward Pharms Revenue Growth Rate in Rufinamide Business (2014-2019)
Table West-ward Pharms Recent Development
Table Global Rufinamide Market Size by Regions (Million US$) 2019-2025
Figure Global Rufinamide Market Size Share by Regions (2019-2025)
Figure Global Rufinamide Market Size Share by Regions in 2025
Figure United States Rufinamide Market Size Forecast (2019-2025)(Million USD)
Figure Europe Rufinamide Market Size Forecast (2019-2025)(Million USD)
Figure China Rufinamide Market Size Forecast (2019-2025)(Million USD)
Figure Japan Rufinamide Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Rufinamide Market Size Forecast (2019-2025)(Million USD)
Figure India Rufinamide Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Rufinamide Market Size Forecast (2019-2025)(Million USD)
Table Global Rufinamide Market Size by Product (2019-2025) (Million US$)
Figure Global Rufinamide Market Size by Product (2019-2025)
Figure Global Rufinamide Market Size by Product in 2025
Table Global Rufinamide Market Size by Application (2019-2025) (Million US$)
Figure Global Rufinamide Market Size by Application (2019-2025)
Figure Global Rufinamide Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のエトラビリン市場：市場規模・現状・予測 Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etrav…- 世界の小児放射線科市場：市場規模・現状・予測 Pediatric radiology is a subspecialty of radiology involving the imaging of fetuses, infants, children, adolescents and young adults.The key factor contributing to the pediatric radiology market is the increasing incidence of diagnosis. In 2018, the global Pediatric Radiology market size was xx mill…
- 世界の小児神経芽細胞腫の治療市場：市場規模・現状・予測 In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017.Based on distribution channel, the global pediatric neuroblastoma treatment market has been categorized into hospital pharmacies and retai…
- 世界のロミプロスチム市場：市場規模・現状・予測 Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production.In 2018, the global Romiplostim market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses o…
- 世界の小児脳腫瘍市場：市場規模・現状・予測 Pediatric brain tumors are masses or growths of abnormal cells that occur in a child's brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant).Treatment and chance of recovery (progn…